Obesity

Showing NaN - NaN of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Sleep Apnea
  • Obesity
  • Riverside, California
  • +66 more
Jan 23, 2023

Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

Recruiting
  • Diabetes Mellitus
  • Obesity
  • Centreville, Alabama
  • +55 more
Jan 18, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Diabetes, Obesity Trial in United States (PF-06882961, Placebo)

Completed
  • Diabetes
  • Obesity
  • Phoenix, Arizona
  • +37 more
Nov 8, 2022

Obesity Trial in United States

Recruiting
  • Obesity
    • Marina Del Rey, California
    • +15 more
    Oct 3, 2022

    Overweight, Obesity Trial in Worldwide (Gelesis100, )

    Completed
    • Overweight
    • Obesity
    • Gelesis100
    • placebo
    • Anaheim, California
    • +35 more
    Aug 8, 2022

    B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Obesity
    • IDEAL2 Intervention
    • Los Angeles, California
    • +15 more
    Jun 23, 2022

    Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Obesity
    • Fairhope, Alabama
    • +97 more
    Jun 15, 2022

    Obesity, Hypertension, Hyperlipidemias Trial in Cincinnati (In-store POP education, Online POP education)

    Completed
    • Obesity
    • +3 more
    • In-store POP education
    • Online POP education
    • Cincinnati, Ohio
      University of Cincinnati Medical Center - UC Health
    Feb 18, 2022

    Overweight, Obesity Trial in United States

    Recruiting
    • Overweight
    • Obesity
      • Little Rock, Arkansas
      • +27 more
      Feb 11, 2022

      Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Semaglutide, Placebo)

      Completed
      • Metabolism and Nutrition Disorder
      • Obesity
      • Anniston, Alabama
      • +71 more
      Jan 7, 2022

      Obesity, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease Trial in Cincinnati (Comprehensive Lifestyle

      Completed
      • Obesity
      • +2 more
      • Comprehensive Lifestyle Intervention
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Nov 1, 2021

      Obesity Trial in Cincinnati (Telehealth Encounter)

      Completed
      • Obesity
      • Telehealth Encounter
      • Cincinnati, Indiana
        Cincinnati Children's Hospital Medical Center
      Feb 1, 2021

      Obesity Trial in Cincinnati (Group nutrition sessions, Fitbit)

      Completed
      • Obesity
      • Group nutrition sessions
      • Fitbit
      • Cincinnati, Ohio
        Pediatric Primary Care Center (PPC) Cincinnati Children's Hospit
      Nov 13, 2020

      Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)

      Unknown status
      • Overweight
      • +3 more
      • Gelesis200
      • Placebo
      • Birmingham, Alabama
      • +29 more
      Jul 20, 2020

      ORBERA™ Post-Approval Study

      Completed
      • Obesity
      • Overweight
        • Little Rock, Arkansas
        • +10 more
        Jul 9, 2020

        Obalon Balloon System Post-Approval Study

        Unknown status
        • Obesity
        • Obalon Balloon System
        • Fountain Valley, California
        • +14 more
        Apr 29, 2020

        Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )

        Completed
        • Metabolism and Nutrition Disorder
        • Obesity
        • Anaheim, California
        • +73 more
        Apr 14, 2020

        Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

        Completed
        • Cardiovascular Disease
        • +4 more
        • Lorcaserin hydrochloride
        • Placebo
        • Alexander City, Alabama
        • +498 more
        Jun 27, 2019

        A Prospective Multicenter Post Approval Study of ReShape™

        Unknown status
        • Obesity
        • Reshape Integrated Dual Balloon
        • Dothan, Alabama
        • +13 more
        Mar 28, 2019

        Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

        Unknown status
        • Endometrial Clear Cell Adenocarcinoma
        • +6 more
        • 3-Dimensional Conformal Radiation Therapy
        • +7 more
        • Birmingham, Alabama
        • +539 more
        Mar 8, 2019

        A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

        Terminated
        • Obesity
        • Overweight
          • Fountain Valley, California
          • +10 more
          Jun 25, 2018

          Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)

          Completed
          • Obesity
          • S-2367 Placebo
          • +4 more
          • Birmingham, Alabama
          • +39 more
          May 9, 2018